Stories

Discover all of the trending stories of Ipsen Group.

Key highlights

Explore more by category

Filter

Period

Filter by

recent search

Sort

Showing: 1 – 10 of 80 stories

Liver Cancer Awareness Month – Rethink liver cancer
 –  – 2 mins read

 – 2 mins read

Liver Cancer Awareness Month – Rethink liver cancer

October is Liver Cancer Awareness Month and this year we are proud to be supporting the European Liver Patients Association (ELPA) with their campaign encouraging everyone to rethink liver cancer by bringing it to the forefront of conversations.


Breast Cancer Awareness Month: raising awareness with inspirational patient stories
 –  – 2 mins read

 – 2 mins read

Breast Cancer Awareness Month: raising awareness with inspirational patient stories

The facts and figures around breast cancer bring into focus the importance of raising awareness of the true scale of this globally prevalent disease. Breast cancer is the most common cancer in women1. It comprises of 24% of all cancers…


Using real-world data for better solutions for patients
 –  – 2 mins read

 – 2 mins read

Using real-world data for better solutions for patients

Innovation to improve patient outcomes doesn’t always resemble the scenes in the movies where the brilliant scientist makes a breakthrough alone in the lab. Sometimes it takes the form of Artificial Intelligence analyzing enormous quantities of data. Sometimes it looks…


Executive Leadership Team Announcement
 –  – 2 mins read

 – 2 mins read

Executive Leadership Team Announcement

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product & Portfolio Strategy and Patrice Zagame, Executive Vice President, Specialty Care International to the Executive Leadership Team (ELT), effective immediately.


David Loew joins Ipsen as CEO
 –  – 1 mins read

 – 1 mins read

David Loew joins Ipsen as CEO

We are delighted to welcome David Loew as the new CEO of Ipsen. A seasoned professional, David’s career has spanned nearly thirty years in the pharmaceutical industry in such companies as Roche and Sanofi. His leadership skills and experience in…


1 13 14 15 16

Discover trending stories

29 November 2023 1 mins read
‘Get men talking’: breaking the silence around prostate cancer

Tim Batchelor, Ipsen’s Head of Global Commercial Learning & Development, candidly shares his experience of living with prostate cancer. At the age of 48, Tim was confronted with a prostate cancer diagnosis. His early detection proved pivotal, leading to successful…

28 November 2023 2 mins read
Primary Biliary Cholangitis: The Power of Patient Reported Outcomes

“The important thing with PBC is to take a holistic view of it, and think ‘What are the problems we are trying to solve? The first is the risk of progression to cirrhosis, and the other is symptoms and quality…

20 November 2023 1 mins read
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics

Starting now and throughout 2024, Ipsen is sponsoring five talented, elite athletes on their journeys toward the 2024 Paralympic Games.

13 November 2023 1 mins read
The Liver Meeting 2023: Innovating for people living with rare liver diseases

Jennifer Schranz (Ipsen’s Global Head of Rare Diseases) attended The Liver Meeting from November 10-14, sharing key insights from her time onsite and explaining why scientific congresses are vital in helping advance innovation for patients. 

10 November 2023 2 mins read
Ipsen’s mission to accelerate innovation in oncology

The outputs from the European Society of Medical Oncology (ESMO) Congress this year encompassed several important new data announcements, highlighting key advances in the development of therapies for people living with cancer.  However, cancer remains a formidable global health challenge,…

10 November 2023 1 mins read
Examining the European Pharma legislation: EFPIA publishes the Dolon Report

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact of the proposed European Commission pharma legislation. The Dolon Report, published on 6 November, has projected that the proposed legislation…

03 November 2023 0 mins read
Capital Markets Day 2023

Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only.

31 October 2023 2 mins read
Ipsen stands together to make innovation in rare disease happen

Developing innovation for people living with rare diseases is uniquely challenging. It requires all the different pieces of the puzzle– clinical viability, economic viability and the policy environment— to come together before innovation can reach patients.

31 October 2023 2 mins read
Innovating for people living with primary biliary cholangitis

At Ipsen we have been focused on developing new and innovative treatments for rare diseases for many years in endocrinology, rare bone disease and more recently in rare liver disease. This focus continues to be a core part of our…

29 October 2023 1 mins read
Rising to the challenge, life after stroke

Globally, stroke is the 2nd leading cause of death worldwide, in addition to being the 3rd leading cause of combined death and disability across the world, with approximately 1 in 4 people over the age of 25 expected to experience…